Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
作者信息
Evans D I, Shaw A
机构信息
Haemophilia Centre, Royal Manchester Children's Hospital.
出版信息
BMJ. 1990 Jun 30;300(6741):1694-5. doi: 10.1136/bmj.300.6741.1694-a.
Abstract
摘要
相似文献
1
Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
BMJ. 1990 Jun 30;300(6741):1694-5. doi: 10.1136/bmj.300.6741.1694-a.
2
Intradermal hepatitis B vaccine.
Lancet. 1989 Mar 18;1(8638):625. doi: 10.1016/s0140-6736(89)91663-2.
3
Present status of recombinant hepatitis B vaccine.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1988 Dec;29 Suppl B:8B-15B.
4
Intradermal vs intramuscular hepatitis B vaccinations.
JAMA. 1990 Jul 11;264(2):181-2. doi: 10.1001/jama.1990.03450020033013.
5
[Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
Gesundheitswesen. 1992 May;54(5):219-22.
6
Hepatitis B vaccines: use in childhood.
N Z Med J. 1988 Apr 13;101(843):165-6.
7
Hepatitis B vaccine: extending immunogenicity.
Br J Hosp Med. 1990 Jun;43(6):409.
8
The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):731-2. doi: 10.1016/0035-9203(90)90167-d.
9
Hepatitis B vaccines.
N Z Med J. 1988 Dec 14;101(859):831.
10
[Response to hepatitis B vaccine in patients with alcoholic liver disease].
Med Clin (Barc). 1991 Sep 21;97(9):353.
引用本文的文献
1
Effectiveness and safety of tetanus vaccine administration by intramuscular vs. subcutaneous route in anticoagulated patients: Randomized clinical trial in primary care.
Front Med (Lausanne). 2022 Dec 22;9:1054988. doi: 10.3389/fmed.2022.1054988. eCollection 2022.
2
COVID-19 vaccines: Frequently asked questions and updated answers.
Infect Dis Now. 2021 Jun;51(4):319-333. doi: 10.1016/j.idnow.2021.02.007. Epub 2021 Feb 27.
3
Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis.
Haemophilia. 2015 Jan;21(1):e39-43. doi: 10.1111/hae.12569. Epub 2014 Nov 7.
4
The safety and efficacy of the tetanus vaccine intramuscularly versus subcutaneously in anticoagulated patients: a randomized clinical trial.
BMC Fam Pract. 2014 Aug 28;15:147. doi: 10.1186/1471-2296-15-147.
5
Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease.
J Geriatr Cardiol. 2014 Jun;11(2):131-5. doi: 10.3969/j.issn.1671-5411.2014.02.007.
6
Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial.
BMC Blood Disord. 2008 May 29;8:1. doi: 10.1186/1471-2326-8-1.
本文引用的文献
1
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
N Engl J Med. 1980 Oct 9;303(15):833-41. doi: 10.1056/NEJM198010093031501.
2
Use of HBV vaccine in hemophiliacs.
Scand J Haematol Suppl. 1984;40:323-8. doi: 10.1111/j.1600-0609.1984.tb02580.x.
3
Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden.
Scand J Haematol Suppl. 1984;40:317-21.
4
Immunogenicity of subcutaneous hepatitis B vaccine in hemophiliacs.
J Pediatr. 1985 Aug;107(2):316. doi: 10.1016/s0022-3476(85)80168-2.
5
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Arch Intern Med. 1989 Jun;149(6):1333-7.
Zotero 插件